Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.17%186.906.2%$90.57m
AMRNAmarin Corporation Plc Sponsored ADR
-0.85%17.451.8%$88.46m
SAGESAGE Therapeutics, Inc.
2.88%175.958.7%$78.55m
PRGOPerrigo Co. Plc
-0.02%49.576.8%$70.54m
ICPTIntercept Pharmaceuticals, Inc.
-1.69%86.2718.6%$65.54m
JAZZJazz Pharmaceuticals Plc
0.72%140.922.3%$64.02m
UTHRUnited Therapeutics Corporation
-0.06%87.0014.3%$58.50m
ZYNEZynerba Pharmaceuticals Inc
-1.77%14.408.3%$44.47m
ICLRICON Plc
0.96%139.354.1%$41.15m
CTLTCatalent Inc
0.44%46.212.4%$36.62m
MDCOMedicines Company
-0.87%32.9621.8%$36.36m
HZNPHorizon Pharma plc
-1.46%25.576.7%$34.65m
MNKMallinckrodt Plc
-1.41%9.1021.0%$34.47m
PCRXPacira Pharmaceuticals, Inc.
-0.96%43.4610.5%$34.28m
AXSMAxsome Therapeutics, Inc.
-0.76%24.902.1%$34.15m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.